Cleared Traditional

K130453 - EXCELSIOR

K130453 is an FDA 510(k) clearance for EXCELSIOR, manufactured by Eyekor, LLC. The device is a Class 2 Ophthalmic device with product code NFJ cleared through the Traditional 510(k) pathway after a 39-day FDA review.

K130453 · Eyekor, LLC · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
39d
Days
Class 2
Risk

K130453 is an FDA 510(k) clearance for the EXCELSIOR. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Eyekor, LLC (North Reading, US). The FDA issued a Cleared decision on April 2, 2013 after a review of 39 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Eyekor, LLC devices

FDA 510(k) Submission Details - K130453

510(k) Number K130453 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 22, 2013
Decision Date April 02, 2013
Days to Decision 39 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 110d · This submission: 39d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NFJ Device Classification - Class 2, Special Controls

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - NFJ System, Image Management, Ophthalmic

All 35
Devices cleared under the same product code (NFJ) and FDA review panel - the closest regulatory comparables to K130453.
Retina Workplace
K150467 · Carl Zeiss Meditec, AG · May 2015
FORUM GLAUCOMA WORKPLACE
K141297 · Carl Zeiss Meditec, AG · Oct 2014
FORUM GLAUCOMA WORKPLACE
K130648 · Carl Zeiss Meditec, AG · Jul 2013
CALLISTO EYE
K123464 · Carl Zeiss Meditec, AG · Mar 2013
FORUM FORUM ARCHIVE FORUM ARCHIVE & VIEWER FORUM ASSIST MATCH
K122938 · Carl Zeiss Meditec, AG · Nov 2012
FORUM
K090439 · Carl Zeiss Meditec, Inc. · Mar 2009